Prevalence and Determinants of Fatigue in Patients with IBD: A Cross-Sectional Survey from the GETAID.

Crohn’s disease disability fatigue inflammatory bowel disease ulcerative colitis

Journal

Journal of Crohn's & colitis
ISSN: 1876-4479
Titre abrégé: J Crohns Colitis
Pays: England
ID NLM: 101318676

Informations de publication

Date de publication:
20 Oct 2023
Historique:
pubmed: 30 3 2023
medline: 30 3 2023
entrez: 29 3 2023
Statut: ppublish

Résumé

Fatigue is commonly reported by patients with inflammatory bowel disease [IBD], but the determinants of IBD-related fatigue have yet to be determined. To identify the factors associated with fatigue in a large population of patients with IBD. Fatigue and nine other IBD-related disability dimensions were assessed in a cohort of 1704 consecutive patients with IBD using the IBD-disk questionnaire in a cross-sectional survey of 42 French and Belgian centres. Fatigue and severe fatigue were defined as energy subscores >5 and >7, respectively. Determinants of fatigue were assessed using univariate and multivariate analyses (odds ratios [ORs] are provided with 95% confidence intervals). The prevalence rates of fatigue and severe fatigue were 54.1% and 37.1%, respectively. Both fatigue and severe fatigue were significantly higher in patients with active disease than in patients with inactive disease [64.9% vs 44.7% and 47.4% vs 28.6%, respectively; p < 0.001 for both comparisons]. In the multivariate analysis stratified by age, sex, type of IBD and IBD activity, fatigue was associated with age >40 years (OR = 0.71 [0.54-0.93]), female sex (OR = 1.48 [1.13-1.93]) and IBD-related sick leave (OR = 1.61 [1.19-2.16]), and joint pain (OR = 1.60 [1.17-2.18]), abdominal pain (OR = 1.78 [1.29-2.45]), regulating defecation (OR = 1.67 [1.20-2.32]), education and work (OR = 1.96 [1.40-2.75]), body image (OR = 1.38 [1.02-1.86]), sleep (OR = 3.60 [2.66-4.88]) and emotions (OR = 3.60 [2.66-4.88]) subscores >5. Determinants of fatigue are not restricted to IBD-related factors but also include social factors, sleep and emotional disturbances, thus supporting a holistic approach to IBD patient care.

Sections du résumé

BACKGROUND BACKGROUND
Fatigue is commonly reported by patients with inflammatory bowel disease [IBD], but the determinants of IBD-related fatigue have yet to be determined.
AIMS OBJECTIVE
To identify the factors associated with fatigue in a large population of patients with IBD.
PATIENTS AND METHODS METHODS
Fatigue and nine other IBD-related disability dimensions were assessed in a cohort of 1704 consecutive patients with IBD using the IBD-disk questionnaire in a cross-sectional survey of 42 French and Belgian centres. Fatigue and severe fatigue were defined as energy subscores >5 and >7, respectively. Determinants of fatigue were assessed using univariate and multivariate analyses (odds ratios [ORs] are provided with 95% confidence intervals).
RESULTS RESULTS
The prevalence rates of fatigue and severe fatigue were 54.1% and 37.1%, respectively. Both fatigue and severe fatigue were significantly higher in patients with active disease than in patients with inactive disease [64.9% vs 44.7% and 47.4% vs 28.6%, respectively; p < 0.001 for both comparisons]. In the multivariate analysis stratified by age, sex, type of IBD and IBD activity, fatigue was associated with age >40 years (OR = 0.71 [0.54-0.93]), female sex (OR = 1.48 [1.13-1.93]) and IBD-related sick leave (OR = 1.61 [1.19-2.16]), and joint pain (OR = 1.60 [1.17-2.18]), abdominal pain (OR = 1.78 [1.29-2.45]), regulating defecation (OR = 1.67 [1.20-2.32]), education and work (OR = 1.96 [1.40-2.75]), body image (OR = 1.38 [1.02-1.86]), sleep (OR = 3.60 [2.66-4.88]) and emotions (OR = 3.60 [2.66-4.88]) subscores >5.
CONCLUSION CONCLUSIONS
Determinants of fatigue are not restricted to IBD-related factors but also include social factors, sleep and emotional disturbances, thus supporting a holistic approach to IBD patient care.

Identifiants

pubmed: 36988620
pii: 7093159
doi: 10.1093/ecco-jcc/jjad060
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1418-1425

Subventions

Organisme : Abbvie

Investigateurs

Aurelien Amiot (A)
Sara Tadbiri (S)
Charlotte Gagniere (C)
Jenny Tannoury (J)
Maria Nachury (M)
Benjamin Pariente (B)
Pauline Wils (P)
Yoram Bouhnik (Y)
Carmen Stefanescu (C)
Xavier Treton (X)
Carole Martins (C)
Mathieu Uzzan (M)
Melanie Serrero (M)
Jerome Filippi (J)
Xavier Hébuterne (X)
Nadia Arab (N)
Virginie Cluzeau (V)
Xavier Roblin (X)
Emilie Del Tedesco (E)
Laurent Beaugerie (L)
Philippe Seksik (P)
Anne Bourrier (A)
Cecilia Landmann (C)
Julien Kirchgesner (J)
Harry Sokol (H)
Guillaume Bouguen (G)
Laurent Siproudhis (L)
Marie DeWitte (M)
Denis Franchimont (D)
Guillaume Savoye (G)
Anthony Buisson (A)
Edouard Louis (E)
Catherine Reenaers (C)
Stephane Nancey (S)
Gilles Boschetti (G)
Claire Gay (C)
Pauline Danion (P)
Bernard Flourié (B)
Vered Abitbol (V)
Georgia Malamut (G)
Jean-Marie Reimund (JM)
Benedicte Caron (B)
Olivier DeWitt (O)
Lucine Vuitton (L)
Nicolas Mathieu (N)
Sandie Pestour (S)
Thomas Chateau (T)
Laurent Peyrin-Biroulet (L)
Camille Zallot (C)
Cyrielle Gilletta (C)
Matthieu Allez (M)
Jean-Marc Gornet (JM)
Clotilde Baudry (C)
Stephanie Viennot (S)
Arnaud Bourreille (A)
Caroline Trang-Poisson (C)
Nina Dib (N)
Hedi Brixi (H)
Guillaume Cadiot (G)
Medina Boualit (M)
Claire Painchart (C)
Laurianne Plastaras (L)
Romain Altwegg (R)
Lucile Boivineau (L)
Mathurin Fumery (M)
Ludovic Caillo (L)
David Laharie (D)
Pauline Riviere (P)
Florian Poullenot (F)
Benoit Coffin (B)
Henri Duboc (H)
Stephane Nahon (S)
Noemie Tavernier (N)
Marion Simon (M)
Baya Coulibaly (B)
Morgane Amil (M)
Duveau Nicolas (D)
Sherine Khater (S)
Mehdi Kaassis (M)
Felix Goutorbe (F)
Driffa Moussata (D)

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Aurelien Amiot (A)

Department of Gastroenterology, Hopitaux Universitaires Bicêtre, AP-HP, Université Paris Saclay, INSERM, Centre for Research in Epidemiology and Population Health, Le Kremlin Bicêtre, France.

Sayma Chaibi (S)

Department of Gastroenterology, Henri Mondor Hospital, Paris Est-Créteil Val de Marne University, Creteil, France.

Yoram Bouhnik (Y)

Department of Gastroenterology, IBD and Nutrition Support, Beaujon Hospital, University Paris 7 Denis Diderot, Clichy, France.

Melanie Serrero (M)

Hôpital Nord, Centre d'investigation Clinique Marseille Nord, Université Méditerranée, Marseille, France.

Jerome Filippi (J)

Department of Gastroenterology and Clinical Nutrition, CHU of Nice, University Côte d'Azur, Nice, France.

Xavier Roblin (X)

Department of Gastroenterology, Saint-Etienne University Hospital, Saint-Etienne, France.

Anne Bourrier (A)

Department of Gastroenterology, AP-HP, Hôpital Saint-Antoine, UPMC Université Paris 6, Paris, France.

Guillaume Bouguen (G)

Department of Gastroenterology, CHU Rennes and University of Rennes, NUMECAN Institute, Rennes, France.

Denis Franchimont (D)

Department of Gastroenterology, Hôpital Erasme, Laboratoire de Gastroenterologie experimentale, ULB, Brussels, Belgium.

Guillaume Savoye (G)

Department of Gastroenterology, Rouen University Hospital, Rouen, France.

Anthony Buisson (A)

Department of Hepato-Gastroenterology, University Hospital Estaing of Clermont Ferrand, Université d'Auvergne, Clermont-Ferrand, France.

Edouard Louis (E)

Department of Gastroenterology, Liège University Hospital, CHU Liège, Belgium.

Stephane Nancey (S)

Department of Gastroenterology, Lyon-Sud Hospital, Hospices Civils de Lyon and INSERM U1111, University Claude Bernard Lyon 1, Lyon, France.

Vered Abitbol (V)

Department of Gastroenterology, Cochin University Hospital, Paris, France.

Jean-Marie Reimund (JM)

Service d'Hépato-Gastroentérologie et d'Assistance Nutritive, Hôpitaux Universitaires de Strasbourg et INSERM U1113, Université de Strasbourg, Strasbourg, France.

Olivier DeWit (O)

Cliniques Universitaires Saint-Luc, UCL, Brussels, Belgium.

Lucine Vuitton (L)

Department of Gastroenterology, Besancon University Hospital, Besancon, France.

Nicolas Mathieu (N)

Department of Hepato-Gastroenterology and Digestive Oncology, Grenoble Alpes University Hospital, Grenoble, France.

Laurent Peyrin-Biroulet (L)

Department of Gastroenterology, Nancy University Hospital, Inserm U1256 NGERE, Lorraine University, Vandoeuvre-les-Nancy, France.

Cyrielle Gilletta (C)

Department of Gastroenterology, Toulouse University Hospital, Toulouse, France.

Matthieu Allez (M)

Department of Gastroenterology, Saint-Louis University Hospital, Paris, France.

Stephanie Viennot (S)

Department of Gastroenterology, Caen University Hospital, Caen, France.

Catherine Le Berre (C)

Hépato-Gastro-Entérologie et Assistance Nutritionnelle, Inserm CIC 1413, Inserm UMR 1235, Institut des Maladies de l'Appareil Digestif (IMAD), Nantes Université, CHU Nantes, Nantes, France.

Nina Dib (N)

Department of HepatoGastroenterology, Angers University Hospital, Angers, France.

Hedia Brixi (H)

Department of GastroEnterology, Reims University Hospital, Rheims, France.

Claire Painchart (C)

Department of Gastroenterology, Valenciennes General Hospital, Valenciennes, France.

Laurianne Plastaras (L)

Department of Hepato-Gastroenterology, Hospital Pasteur, Colmar, France.

Romain Altwegg (R)

Department of Gastroenterology, Hôpital Saint-Eloi, University Hospital of 28 Montpellier, Montpellier, France.

Mathurin Fumery (M)

Service d'Hépato-gastroentérologie, Centre Hospitalier Universitaire Amiens-Picardie Site Sud, Amiens, Hauts-de-France, France.

Ludovic Caillo (L)

Department of Gastroenterology, Nimes University Hospital, Nimes, France.

David Laharie (D)

CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-gastroentérologie et oncologie digestive - Université de Bordeaux, F-33000 Bordeaux, France.

Maria Nachury (M)

Univ. Lille, INSERM, CHU Lille, U1286 - INFINITE - Institute for Translational Research in Inflammation, F-59000 Lille, France.

Classifications MeSH